Portfolio company
Noninvasix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops non-invasive optoacoustic monitoring technology to measure central venous oxygenation levels for clinicians treating patients with sepsis and septic shock.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
PATH EX, Inc.
This company develops a medical device that removes bacteria and endotoxins from the bloodstream to treat sepsis patients in clinical settings.
Novus Diagnostic
Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.
FAST Biomedical
This company develops medical technology for measuring blood volume and kidney function to assist healthcare professionals treating heart failure and sepsis patients.
Inflammatix
This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Odi Medical AS
The company develops non-invasive technology for assessing microvascular oxygen delivery to help clinicians with patient triaging and treatment monitoring.
